Attitudes Toward Human Papillomavirus & Influenza Vaccination Among

See also
Status	Clinical Trial	Phase
Completed	`NCT03246100` - Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado	N/A
Terminated	`NCT01195779` - Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children	Phase 2
Completed	`NCT02761551` - Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates	N/A
Recruiting	`NCT05298800` - Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23	Phase 4
Completed	`NCT03735147` - Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children	Phase 4
Completed	`NCT02831608` - Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis	Phase 4
Completed	`NCT02560909` - Adjuvanted Influenza Vaccine in Stem Cell Transplant	Phase 4
Withdrawn	`NCT01623232` - MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly	Phase 1/Phase 2
Completed	`NCT00961337` - Evaluation of a School-based Influenza Vaccination Program	Phase 4
Completed	`NCT00402805` - Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy	Phase 4
Completed	`NCT00222638` - Influenza Vaccination and Oral Anticoagulant Therapy	Phase 4
Active, not recruiting	`NCT03734237` - A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD	Phase 4
Completed	`NCT01013675` - Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly	Phase 2
Completed	`NCT00306995` - Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population	Phase 2
Completed	`NCT01310413` - Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age	Phase 3
Completed	`NCT00449670` - Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults	Phase 3
Completed	`NCT01788228` - Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure	Phase 3
Completed	`NCT00296270` - Memory for Flu Facts and Myths and Effects on Vaccine Intentions	N/A
Recruiting	`NCT05521763` - Influenza Vaccine Uptake Among Healthcare Workers	N/A
Completed	`NCT00718120` - Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years	Phase 3

NCT number	NCT02358083
Study type	Interventional
Source	Indiana University
Contact
Status	Completed
Phase	N/A
Start date	August 2014
Completion date	August 2014

Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms